Skip to main content
Premium Trial:

Request an Annual Quote

Ionian Gets $2.7M DARPA Contract to Develop Hand-Held Biodetectors

NEW YORK, March 25 (GenomeWeb News) - Ionian Technologies has received a $2.7 million contract from the DoD's Defense Advanced Research Projects Agency to develop hand-held rapid detectors of biological agents, the company said yesterday.


Ionian, located in Upland, Calif., will develop assays and chemistry based on a DNA detection technology, Expar, that it licenses from the Keck Graduate Institute in Claremont, Calif., a subcontractor for the project.


Expar allows researchers to amplify nucleic acids isothermally and rapidly.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.